MT2A and esophageal cancer: They showed that ECRG2 directly interacted with metallothionein 2A (MT2A), and the ECRG2-mediated modulation of MT2A function was thought to be a possible mechanism via which ECRG2 suppresses esophageal cancer cell growth [1].